Navigation Links
Cell Therapeutics, Inc. (CTI) Projects Zevalin(R) Sales of $15 Million With Cash Flow Breakeven for Commercial Operations in 2008
Date:2/11/2008

ous adverse reactions of the Zevalin therapeutic regimen were primarily hematologic, including neutropenia, thrombocytopenia, and anemia. Infusion-related toxicities were associated with pre-administration of rituximab. The risk of hematologic toxicity correlated with the degree of bone marrow involvement prior to Zevalin therapy. Myelodysplasia or acute myelogenous leukemia was observed in 2 percent of patients (8 to 34 months after treatment). Zevalin should only be used by health care professionals qualified by training and experience in the safe use of radionuclides.

Patients and healthcare professionals can visit http://www.zevalin.com for more information.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit http://www.cticseattle.com.

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results. Specifically, the risks and uncertainties that could affect the marketing and development of Zevalin, or the development of XYOTAX and pixantrone include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general and with Zevalin, XYOTAX, and pixantrone in particular including, without limitation, the potential failure of these product candidates to prove safe and effective for treatment of non-small cell lung cancer, ovarian cancer, and non-Hodgkin's lymphoma, determinations by regulatory, patent and administrative governmental authorities, competitive factors, technological developments, costs of developing, producing and selling Zevalin, XYOTAX, and pixantrone. In addition, we ma
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Cell Therapeutics, Inc. (CTI) to Present at 10th Annual BIO CEO & Investor Conference
2. Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference
3. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
4. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
5. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
6. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
7. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
8. Cell Therapeutics, Inc. (CTI) Prices $1.27 million (euros 856.000) Offering of Common Stock through Societe Generale
9. Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus
10. Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
11. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...TA and LACHEN, Switzerland, Dec. 4 ...ounced that Dennis D. Curtin has been,selected to... States. Curtin,had been Octapharma,s U.S. legal ...t of Life Therapeutics, Inc. , The largest ...pharma,recently acquired Life Therapeutics, the A...
(Date:12/4/2008)...ORK, Dec. 4 NeoStem, Inc...he pre-disease collection,processing and long-te...need,today announced that it has reached a major...opening of the first ever collection center for co...c for future medical need in New York,City and ha...
(Date:12/4/2008)...N, December 4 Azur Pharma Limited ... a definitive agreement with BioSante,Pharmaceuti... U.S. rights to,Elestrin(TM). Elestrin is a fast ...cated for the treatment of moderate to severe vaso...n was approved by the U.S. Food and Drug,Administ...
(Date:12/4/2008)...M, N.C., Dec. 4 Parion Sciences, I...nces (Nasdaq: GILD ), has initiated a Phase I,c...valuate the safety and,tolerability of the invest...e,airway hydration for the treatment of pulmonary...n epithelial sodium channel (ENaC) blocker discove...
Breaking Biology Technology:Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 2NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 3NeoStem's New York City Adult Stem Cell Collection Center Has Opened and Begun Collections 4Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 3
...e only System for Quantitative PCR that is as Flex... , , , , Choose the LightCycle...ble enough to meet your changing research needs. C... LightCycler Instrument which is much , m...mpletely new integrated , system with a r...
... for amplification of GC-rich targets (up to ,...0 PCR reactions , , , , , , ...zyme blend of Taq DNA Polymerase and , Pwo ...eading (3,5, exonuclease) , activity]. ,... , An optimized GC-RICH PCR reaction...
... Highly purified deoxynucleotides for optimal ,...and RT-PCR applications, , , , ... Nucleotides! , Produce sensitive and consi..., deoxy-nucleotides from RAS. Improve perfor...ssays, even when analyzing low copy number targets...
... for one-step RT-PCR amplification of up to ,...ions , Cat. No. 2 016 346 250 reactions ,... , , The system contains a unique enzyme ... Polymerase. , , Note: C. therm. Po...recombinant , form of the DNA polymerase fr...
Other Biology Technology:The LightCycler is the only System for Quantitative PCR that is as Flexible , as, You are! 2The LightCycler is the only System for Quantitative PCR that is as Flexible , as, You are! 3The LightCycler is the only System for Quantitative PCR that is as Flexible , as, You are! 4GC-RICH PCR System 2PCR Grade Deoxynucleotides 2PCR Grade Deoxynucleotides 3PCR Grade Deoxynucleotides 4PCR Grade Deoxynucleotides 5C. therm. Polymerase One-Step RT-PCR System 2C. therm. Polymerase One-Step RT-PCR System 3
(Date:12/4/2008)...often touting their intelligence and their high in...versity and Oxford University that studied 400 lon...tners. , Research in the theory of evolution inc...and women choose their partners. Among the more e... attractive appearance, whereas resources and soci...
(Date:12/3/2008)...irector of the International Energy Agency, will p...ice University,s Baker Institute for Public Policy... world facing a supply crunch because of geology o...olicy framework might stabilize greenhouse gases a...such a policy framework have on future energy choi...
(Date:12/3/2008)...he first 5-year forest inventory report for Oregon...e public: Oregon,s Forest Resources, 2001-2005: Fi...Here are some key findings from the report:, , ...t half of Oregon,s total land area of 61 million a...ses particularly near urban areas. The rate of con...
(Date:12/3/2008)...udy suggests that evolution can behave as differen...energy-efficient style of four-footed running over...have evolved a profoundly inefficient gait, tailor...n. , "It is usually assumed that efficiency is w...Duke associate professor of evolutionary anthropol...
Breaking Biology News(10 mins):Myth about 'dirty old men' supported by science 2'World Energy Outlook' to be presented at Rice University Dec. 9 2Forest inventories in Oregon include more than trees 2Forest inventories in Oregon include more than trees 3Dogs chase efficiently, but cats skulk counterintuitively 2FDA Extends Review of Genasense 28R 29 NDA Appeal in Chronic Lymphocytic Leukemia 1190 1FDA Extends Review of Genasense 28R 29 NDA Appeal in Chronic Lymphocytic Leukemia 1190 2FDA Extends Review of Genasense 28R 29 NDA Appeal in Chronic Lymphocytic Leukemia 1190 3American Chemical Societys weekly PressPac Jan 9 2008 1879 1American Chemical Societys weekly PressPac Jan 9 2008 1879 2American Chemical Societys weekly PressPac Jan 9 2008 1879 3American Chemical Societys weekly PressPac Jan 9 2008 1879 4American Chemical Societys weekly PressPac Jan 9 2008 1879 5American Chemical Societys weekly PressPac Jan 9 2008 1879 6American Chemical Societys weekly PressPac Jan 9 2008 1879 7American Chemical Societys weekly PressPac Jan 9 2008 1879 8American Chemical Societys weekly PressPac Jan 9 2008 1879 9U S Food Safety 3A A Grocery List of Tainted Products 9498 1U S Food Safety 3A A Grocery List of Tainted Products 9498 2Smile 21 Make Your New Years Resolutions a Reality This Year 9494 1Smile 21 Make Your New Years Resolutions a Reality This Year 9494 2Smile 21 Make Your New Years Resolutions a Reality This Year 9494 3
...ntal conditions in the Canadian Rockies are stifli..., say University of Alberta researchers. , Smaller...ult of human activities--are diminishing the alpin...ld lead to the butterflies being less able to surv...at the University of Alberta and an author of a pa...
...ances our ability to discern the ancient evolution...r biological functions, researchers have provided ...ene duplication that occurred over a hundred milli...work is reported in Current Biology by a team led ...and. , Gene duplication--a relatively uncommon eve...
...ake of Hurricane Katrina, scientists and research ...enerate information on the contaminated floodwater...public health officials. , In a matter of hours, t...arine Sciences Program and Renaissance Computing I...r for Supercomputing Applications (NCSA), played a...
...leading public repositories for DNA and RNA sequen...,000,000 bases; the ,letters, of the genetic code]..., which has paved the way for the global exchange ... members of the International Nucleotide Sequence ...rg ] - EMBL Bank [Hinxton, UK], GenBank [Bethesda,...
Other Biology News:Expanding forests darken the outlook for butterflies, study shows 2Analysis of flower genes reveals the fate of an ancient gene duplication 2UNC computer, marine scientists collaborate to predict flow of toxic waters from Katrina 2UNC computer, marine scientists collaborate to predict flow of toxic waters from Katrina 3Public collections of DNA and RNA sequence reach 100 gigabases 2Public collections of DNA and RNA sequence reach 100 gigabases 3
...lvement of integrins in vascular proliferation, ad.... The integrin family of cell adhesion receptors c...imers, composed of an a and b subunit that associa...ctional diversity of the integrin family are based...
...ep ion exchange media are rigid macroporous hydrop...flow rates at moderate pressures, while the macrop... hydrophilic matrix reduces nonspecific binding. M... anion exchanger with very high flow rates and res...
siTrio siRNA --- a cocktail of 3 siRNAs specifically targeted to your target gene of interestis our most popular product. The siTrio reagent guarantees you get more than 75% knockdown of your target
Mouse monoclonal [BC-4] to Aggrecan xxPEN ( Abpromise for all tested applications). entrezGeneID: 176 SwissProtID: P16112
Biology Products: